Capital Planning Advisors LLC cut its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 56.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,305 shares of the company’s stock after selling 1,683 shares during the period. Capital Planning Advisors LLC’s holdings in Procter & Gamble were worth $219,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Concurrent Investment Advisors LLC boosted its stake in Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after purchasing an additional 4,035 shares in the last quarter. Copley Financial Group Inc. acquired a new stake in Procter & Gamble in the 3rd quarter worth approximately $668,000. Fortem Financial Group LLC acquired a new stake in Procter & Gamble in the 4th quarter worth approximately $569,000. Nordea Investment Management AB boosted its stake in Procter & Gamble by 7.5% in the 4th quarter. Nordea Investment Management AB now owns 2,898,569 shares of the company’s stock worth $484,583,000 after purchasing an additional 201,695 shares in the last quarter. Finally, Synovus Financial Corp boosted its stake in Procter & Gamble by 3.4% in the 3rd quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after purchasing an additional 6,077 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
Shares of NYSE PG opened at $164.41 on Friday. The firm has a market cap of $387.20 billion, a PE ratio of 26.18, a PEG ratio of 3.69 and a beta of 0.45. The firm has a fifty day moving average of $168.96 and a 200 day moving average of $169.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.55 and a current ratio of 0.76. The Procter & Gamble Company has a one year low of $152.06 and a one year high of $180.43.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 annualized dividend and a yield of 2.45%. Procter & Gamble’s dividend payout ratio (DPR) is presently 64.01%.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on PG shares. Morgan Stanley raised their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Stifel Nicolaus raised their price target on shares of Procter & Gamble from $161.00 to $165.00 and gave the stock a “hold” rating in a research report on Thursday. JPMorgan Chase & Co. reduced their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. Evercore ISI raised their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Finally, Barclays raised their price target on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a research report on Thursday. Eight analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $180.53.
View Our Latest Report on Procter & Gamble
Insiders Place Their Bets
In other news, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the transaction, the insider now directly owns 11,595 shares in the company, valued at approximately $2,002,804.35. The trade was a 52.47 % decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by corporate insiders.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- ESG Stocks, What Investors Should Know
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.